AdaptHealth Posts $168.2 Million Third-Quarter Loss
The loss followed a $184.8 million goodwill impairment, and the company cut its 2026 free cash flow guidance.
Updated on Nov. 16, 2026 in Healthcare

AdaptHealth Corp. reported a $168.2 million net loss for the third quarter ended Sept. 30, 2026, compared with net income of $10.2 million a year earlier. The company also lowered its 2026 free cash flow guidance to $50 million to $75 million.
Why it matters
The loss was driven largely by a noncash goodwill impairment, while the company is restructuring around Sleep Health, Respiratory Health and Wellness-at-Home services. Its planned $235 million sale of the Diabetes Health business reflects that shift in focus.
Nine-month free cash flow dropped to $2.6 million from $140.1 million a year earlier, and operating cash flow totaled $395.6 million versus $418.6 million. Revised 2026 revenue guidance is $2.88 billion to $2.90 billion.
The players
AdaptHealth Corp.
AdaptHealth is a publicly traded home medical equipment and healthcare services company headquartered in Conshohocken, Pennsylvania, focused on sleep, respiratory and home-based care.
The details
Organic revenue grew 12.8%, and registered myAPP users exceeded 615,000, roughly 88% above year-end 2025. Lower utilization under a capitated agreement and reduced labor expenses partly offset the pressure from the impairment charge.
Timeline
Sept. 30, 2026: Quarter ended, with the reported $168.2 million loss
Early 2027: Expected closing of the Diabetes Health sale, subject to remaining approvals
Industry Landscape
AdaptHealth's restructuring toward sleep, respiratory and home-based services reflects a broader move among home medical equipment providers to narrow portfolios and reduce exposure to lower-margin lines. Capitated arrangements with payers add volatility to utilization and labor costs, which the company cited as partial offsets this quarter.
Patients relying on AdaptHealth's sleep, respiratory and home-based equipment should see no immediate change from this report, which concerns the company's financial results. The pending Diabetes Health sale may affect which products and services are offered in the future.
The takeaway
Quarterly losses driven by noncash impairments can differ sharply from underlying operating performance, so readers should look at cash flow and organic growth alongside headline net results.
Further reading
Explore more Healthcare coverage for context on how providers are adjusting to payment and cost pressures.
Source note: This article includes information reported by MyChesCo.






